Literature DB >> 28025218

Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study.

Kathrine B Sondergaard1, Peter Weeke2, Mads Wissenberg1,3, Anne-Marie Schjerning Olsen1, Emil L Fosbol2, Freddy K Lippert3, Christian Torp-Pedersen4, Gunnar H Gislason1,5, Fredrik Folke1,3.   

Abstract

Aims: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and have been associated with increased cardiovascular risk. Nonetheless, it remains unknown whether use of NSAIDs is associated with out-of-hospital cardiac arrest (OHCA). Methods and results: From the nationwide Danish Cardiac Arrest Registry, all persons with OHCA during 2001-10 were identified. NSAID use 30 days before OHCA was categorized as follows: diclofenac, naproxen, ibuprofen, rofecoxib, celecoxib, and other. Risk of OHCA associated with use of NSAIDs was analysed by conditional logistic regression in case-time-control models matching four controls on sex and age per case to account for variation in drug utilization over time. We identified 28 947 persons with OHCA of whom 3376 were treated with an NSAID up to 30 days before OHCA. Ibuprofen and diclofenac were the most commonly used NSAIDs and represented 51.0% and 21.8% of total NSAID use, respectively. Use of diclofenac (odds ratio [OR], 1.50 [95% confidence interval (CI) 1.23-1.82]) and ibuprofen [OR, 1.31 (95% CI 1.14-1.51)] was associated with a significantly increased risk of OHCA. Use of naproxen [OR, 1.29 (95% CI 0.77-2.16)], celecoxib [OR, 1.13 (95% CI 0.74-1.70)], and rofecoxib (OR, 1.28 [95% CI 0.74-1.70)] was not significantly associated with increased risk of OHCA; however, these groups were characterized by few events.
Conclusion: Use of non-selective NSAIDs was associated with an increased early risk of OHCA. The result was driven by an increased risk of OHCA in ibuprofen and diclofenac users. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Diclofenac; Ibuprofen; NSAID; OHCA; Pharmacoepidemiology

Mesh:

Substances:

Year:  2017        PMID: 28025218     DOI: 10.1093/ehjcvp/pvw041

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


  13 in total

Review 1.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

2.  Effect of Mobile Device-Assisted N-of-1 Trial Participation on Analgesic Prescribing for Chronic Pain: Randomized Controlled Trial.

Authors:  David D Odineal; Maria T Marois; Deborah Ward; Christopher H Schmid; Rima Cabrera; Ida Sim; Youdan Wang; Barth Wilsey; Naihua Duan; Stephen G Henry; Richard L Kravitz
Journal:  J Gen Intern Med       Date:  2019-08-28       Impact factor: 5.128

3.  Biological characterization of new inhibitors of microsomal PGE synthase-1 in preclinical models of inflammation and vascular tone.

Authors:  Karin Larsson; Julia Steinmetz; Filip Bergqvist; Samsul Arefin; Linda Spahiu; Johan Wannberg; Sven-Christian Pawelzik; Ralf Morgenstern; Patric Stenberg; Karolina Kublickiene; Marina Korotkova; Per-Johan Jakobsson
Journal:  Br J Pharmacol       Date:  2019-12-28       Impact factor: 8.739

Review 4.  [Perioperative analgesia with nonopioid analgesics : Joint interdisciplinary consensus-based recommendations of the German Pain Society, the German Society of Anaesthesiology and Intensive Care Medicine and the German Society of Surgery].

Authors:  Ulrike M Stamer; Joachim Erlenwein; Stephan M Freys; Thomas Stammschulte; Dirk Stichtenoth; Stefan Wirz
Journal:  Anaesthesist       Date:  2021-07-19       Impact factor: 1.041

Review 5.  [Perioperative analgesia with nonopioid analgesics : Joint interdisciplinary consensus-based recommendations of the German Pain Society, the German Society of Anaesthesiology and Intensive Care Medicine and the German Society of Surgery].

Authors:  Ulrike M Stamer; Joachim Erlenwein; Stephan M Freys; Thomas Stammschulte; Dirk Stichtenoth; Stefan Wirz
Journal:  Chirurg       Date:  2021-05-26       Impact factor: 0.955

Review 6.  The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis.

Authors:  Megan Yu; Sheng-Feng Tsai; Yu-Min Kuo
Journal:  Int J Mol Sci       Date:  2017-06-13       Impact factor: 5.923

7.  A database of tissue-specific rhythmically expressed human genes has potential applications in circadian medicine.

Authors:  Marc D Ruben; Gang Wu; David F Smith; Robert E Schmidt; Lauren J Francey; Yin Yeng Lee; Ron C Anafi; John B Hogenesch
Journal:  Sci Transl Med       Date:  2018-09-12       Impact factor: 17.956

Review 8.  [Perioperative analgesia with nonopioid analgesics : Joint interdisciplinary consensus-based recommendations of the German Pain Society, the German Society of Anaesthesiology and Intensive Care Medicine and the German Society of Surgery].

Authors:  Ulrike M Stamer; Joachim Erlenwein; Stephan M Freys; Thomas Stammschulte; Dirk Stichtenoth; Stefan Wirz
Journal:  Schmerz       Date:  2021-08       Impact factor: 1.107

9.  Polyglycerol-opioid conjugate produces analgesia devoid of side effects.

Authors:  Sara González-Rodríguez; Mohiuddin A Quadir; Shilpi Gupta; Karolina A Walker; Xuejiao Zhang; Viola Spahn; Dominika Labuz; Antonio Rodriguez-Gaztelumendi; Martin Schmelz; Jan Joseph; Maria K Parr; Halina Machelska; Rainer Haag; Christoph Stein
Journal:  Elife       Date:  2017-07-04       Impact factor: 8.140

10.  Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case-control study.

Authors:  Mohammad Bakhriansyah; Patrick C Souverein; Olaf H Klungel; Anthonius de Boer; Marieke T Blom; Hanno L Tan
Journal:  Europace       Date:  2019-01-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.